Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. 252, doi. 10.1002/phar.1713
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2016 AND VI 36 AND IP 3
Results: 14
1
2
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. 317, doi. 10.1002/phar.1714
- By:
- Publication type:
- Article
3
Do Statins Attenuate Postoperative Atrial Fibrillation in Isolated Heart Valve Surgery?
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. e16, doi. 10.1002/phar.1715
- By:
- Publication type:
- Article
4
Impact of Stewardship Interventions on Antiretroviral Medication Errors in an Urban Medical Center: A 3-Year, Multiphase Study.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. 245, doi. 10.1002/phar.1716
- By:
- Publication type:
- Article
5
Nabilone for the Management of Pain.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. 273, doi. 10.1002/phar.1709
- By:
- Publication type:
- Article
6
Author’s Reply.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. e17
- By:
- Publication type:
- Article
7
Issue Infomation.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. 239, doi. 10.1002/phar.1720
- Publication type:
- Article
8
Effectiveness of a Pharmacist-Physician Team-Based Collaboration to Improve Long-Term Blood Pressure Control at an Inner-City Safety-Net Clinic.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. 342, doi. 10.1002/phar.1710
- By:
- Publication type:
- Article
9
Implementation and Clinical Outcomes of an Employer-Sponsored, Pharmacist-Provided Medication Therapy Management Program-Alternative Viewpoint.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. e15, doi. 10.1002/phar.1724
- By:
- Publication type:
- Article
10
Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. 287, doi. 10.1002/phar.1711
- By:
- Publication type:
- Article
11
Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. 263, doi. 10.1002/phar.1717
- By:
- Publication type:
- Article
12
Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. 300, doi. 10.1002/phar.1712
- By:
- Publication type:
- Article
13
Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. 335, doi. 10.1002/phar.1718
- By:
- Publication type:
- Article
14
Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 3, p. 348, doi. 10.1002/phar.1719
- By:
- Publication type:
- Article